flutiform is the first pressurised metered-dose inhaler to combine the ICS, fluticasone propionate, with the fast-acting inhaled LABA, formoterol. 2 flutiform is licensed for asthma maintenance ...
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...
U.K.-based SkyePharma's Flutiform, an inhaled combination of fluticasone and formoterol, has been launched in Germany by the company's partner, Mundipharma, as an asthma maintenance therapy.
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma. Napp Pharmaceuticals says the UK is ...
DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...
There was good news for Cambridge, UK-based Napp Pharmaceuticals this week as cost regulators in Scotland approved the use of its asthma inhaler Flutiform for National Health Service use. There was ...
k-haler is an award-winning[3] breath-triggered aerosol device utilising a patented "kinked" valve - the k-valve(TM) which has been designed with the aim to make it easier for patients to use ...
LONDON (MarketWatch) -- U.K. drug delivery company SkyePharma PLC Tuesday said it has signed a deal with Kyorin Co. Ltd. (4569.TO) to develop and distribute its key experimental product, asthma ...
- flutiform k-haler achieved high levels of lung deposition of over 44% of delivered dose - Plume force of flutiform k-haler was compared with fluticasone propionate/salmeterol xinafoate delivered via ...
It's likely that SkyePharma isn't having a "Happy New Year" just yet. That's because the British drug delivery company now stands to face an additional delay of between 6 and 9 months in the approval ...
- flutiform k-haler is now available in Europe as an asthma treatment for adults and adolescents (aged 12 years and older)[1] - Research indicates that many patients make errors with their inhalers ...
flutiform k-haler, a Novel Treatment for Adolescents and Adults With Asthma, Now Available in Europe
flutiform k-haler is now available in Europe as an asthma treatment for adults and adolescents (aged 12 years and older) [1] Research indicates that many patients make errors with their inhalers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results